CoChat
Sign Up
Cited by 195Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

The DOI matches its Crossref record; 66 of the 68 references it cites were found in a registry or an index.

Continuous Glucose Monitoring: A Consensus Conference of the American Association of Clinical Endocrinologists and American College of Endocrinology

Open access
Fonseca, Vivian A., Grunberger, George, Anhalt, Henry, Bailey, Timothy S., Blevins, Thomas, Garg, Satish K., Handelsman, Yehuda, Hirsch, Irl B., Orzeck, Eric A., Roberts, Victor Lawrence, Tamborlane, William·2016·Endocrine Practice
DOI 10.4158/ep161392.cs
Open this paper in CoChat — free account

Abstract

Objective/methods Barriers to continuous glucose monitoring (CGM) use continue to hamper adoption of this valuable technology for the management of diabetes. The American Association of Clinical Endocrinologists and the American College of Endocrinology convened a public consensus conference February 20, 2016, to review available CGM data and propose strategies for expanding CGM access.Results Conference participants agreed that evidence supports the benefits of CGM in type 1 diabetes and that these benefits are likely to apply whenever intensive insulin therapy is used, regardless of diabetes type. CGM is likely to reduce healthcare resource utilization for acute and chronic complications, although real-world analyses are needed to confirm potential cost savings and quality of life improvements. Ongoing technological advances have improved CGM accuracy and usability, but more innovations in human factors, data delivery, reporting, and interpretation are needed to foster expanded use. The development of a standardized data report using similar metrics across all devices would facilitate clinician and patient understanding and utilization of CGM. Expanded CGM coverage by government and private payers is an urgent need.Conclusion CGM improves glycemic control, reduces hypoglycemia, and may reduce overall costs of diabetes management. Expanding CGM coverage and utilization is likely to improve the health outcomes of people with diabetes.Abbreviations A1C = glycated hemoglobin AACE = American Association of Clinical Endocrinologists ACE = American College of Endocrinology ASPIRE = Automation to Simulate Pancreatic Insulin Response CGM = continuous glucose monitoring HRQOL = health-related quality of life ICER = incremental cost-effectiveness ratio JDRF = Juvenile Diabetes Research Foundation MARD = mean absolute relative difference MDI = multiple daily injections QALY = quality-adjusted life years RCT = randomized, controlled trial SAP = sensor-augmented pump SMBG = self-monitoring of blood glucose STAR = Sensor-Augmented Pump Therapy for A1C Reduction T1D = type 1 diabetes T2D = type 2 diabetes.

Overview

Integrity signals

Registry

Crossref · 10.4158/ep161392.cs

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 68 references

Research works printed but not linked: 1

  1. Miller, 2016, Continuous glucose monitoring in T1D patients using injections of insulin: a report from the T1D Exchange clinic registry, Diabetes Technol Ther, 18, A

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Fonseca, V. A., Grunberger, G., Anhalt, H., Bailey, T. S., Blevins, T., Garg, S. K., Handelsman, Y., Hirsch, I. B., Orzeck, E. A., Roberts, V. L., & Tamborlane, W.
Affiliations
  • Tulane University (US)
  • Oakland University (US)
  • T1D Exchange (US)
  • University of California San Diego (US)
  • Texas Diabetes & Endocrinology (US)
  • University of Colorado Anschutz (US)
  • University of Washington (US)
  • University of Central Florida (US)
  • Yale University (US)
ORCID
Venue
Endocrine Practice
Publisher
Elsevier BV
Published
2016-08
Volume
22
Issue
8
Pages
1008-1021
ISSN
1530-891X (ISSN-L)
DOI
10.4158/ep161392.cs
OpenAlex
W2406099149
Cited by
195
References
68
Citations by year
2026: 6 · 2025: 12 · 2024: 12 · 2023: 9 · 2022: 14 · 2021: 19 · 2020: 23 · 2019: 33 · 2018: 27 · 2017: 38 · 2016: 2
FWCI
33.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Endocrine Practice (publishedVersion)
  • PubMed (publishedVersion)
  • Journal of International Crisis and Risk Communication Research (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
continuous glucose monitoring, diabetes management, type 1 diabetes, type 2 diabetes, intensive insulin therapy, glycemic control, hypoglycemia, healthcare resource utilization, cost-effectiveness, insurance coverage, sensor-augmented pump therapy, self-monitoring of blood glucose, health-related quality of life
MeSH terms
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Endocrinology, Humans, Quality of Life, Blood Glucose Self-Monitoring, Consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review